Joyce Heinzerling Davis
Directeur/Membre du Conseil chez KOP Therapeutics Corp.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Tibor Gajdics | M | 65 |
KOP Therapeutics Corp.
 KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 6 ans |
| Ian Hollis Mann | M | 66 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 5 ans |
| Mark Redcliffe | M | - |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | - |
| Marco Strub | M | 68 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | - |
| Jakson Inwentash | M | 30 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 2 ans |
| Aziz-Ur Rehman | M | 51 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 3 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Canada | 6 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Joyce Heinzerling Davis
- Réseau Personnel
